The Mimic Problem: Five Diagnostic Traps Where Psychedelic Exposure Fooled the Differentials

Why This List Exists

Most veterinary toxicology curricula were built around a canon: xylitol, chocolate, permethrin, rodenticide, the cane toad. Serotonergic entheogens — MDMA, ketamine, LSD, psilocybin — appear mostly as footnote compounds, relegated to 'recreational exposure' appendices. Yet as household availability of these substances has risen, so has the frequency with which companion animals present to clinics with exposure histories nobody mentions.

The five cases below, drawn from anonymized case reports and practitioner interviews, share a common thread: the initial differential was wrong, and the correct one only surfaced after a change in history-taking or a diagnostic dead end. The lesson is not that psychedelics are uniquely dangerous. It is that they are uniquely mimetic — and that a few pointed questions can save hours.

Case 1: The 'Chocolate Ingestion' That Wasn't

A three-year-old Labrador presented with tachycardia, hyperthermia, and agitation. The owner reported a possible chocolate exposure. The team initiated standard methylxanthine management and monitored. When tremors worsened rather than improved, a housemate admitted the dog had consumed a bag of MDMA tablets intended for a festival weekend.

The serotonergic picture — myoclonus, hyperreflexia, hyperthermia disproportionate to the ingestion timeline — was retrospectively obvious. The red flag: chocolate rarely produces hyperreflexia without concurrent gastrointestinal signs this early. Cyproheptadine and active cooling turned the case around.

Case 2: Ketamine Masquerading as Trauma

A cat presented recumbent, ataxic, with horizontal nystagmus. The working differential was head trauma from a suspected fall. Radiographs were clean. Only after the internist noted a disproportionate dissociative quality — the cat was responsive but 'elsewhere' — did the team test the urinary tract of the question differently: had anything in the household been recently dispensed for another pet's procedure?

It had. A bottle of ketamine prescribed for a resident dog's post-op analgesia, with teeth marks on the cap. Red flag: dissociative recumbency without corresponding injury findings should prompt a pharmacy audit of the household.

Case 3: LSD and the 'Seizure' Workup

A young terrier mix presented with apparent generalized seizure activity and bizarre posturing. The workup — CBC, chemistry, bile acids, MRI — was unrevealing. Three thousand dollars later, a neighbor mentioned that teenagers had been 'dosing' in the garage where the dog slept.

The red flag: true epileptiform activity on presentation is rarely accompanied by sustained mydriasis and hallucinatory behavior (snapping at nonexistent insects). When the neurologic exam doesn't localize, broaden the toxicology conversation.

Case 4: Psilocybin Presenting as Gastroenteritis

Mushroom ingestion cases usually trigger a hepatotoxicity protocol — amatoxin panic. But a backyard-harvested Psilocybe stash consumed by a beagle produced a very different picture: ataxia, vocalization, and mild GI upset with no rising liver values. The initial workup assumed the former and nearly missed supportive care timing for the latter.

The red flag: behavioral changes out of proportion to GI signs in a mushroom case should prompt mycological identification, not just hepatic monitoring.

Case 5: The DMSO-and-DMT Freeze Frame

Perhaps the most instructive: a dog exposed to a home-brewed 5-MeO-DMT solution stored in a freezer. Presentation mimicked cane toad envenomation — a reasonable initial assumption in the Southwest. But the absence of cardiac conduction abnormalities and the prominence of serotonergic signs redirected the team toward 5-HT antagonism as the core intervention.

The red flag: regional assumptions are useful, but they can anchor a workup to the wrong pharmacology.

The Ethics of Asking

There is a final layer, and it belongs in this publication's pages: practitioners report hesitancy to ask about Schedule I household substances, and owners report hesitancy to answer. That silence is a clinical hazard. Framing the question non-accusatorially — 'does anyone in the home use or store any substances, plant-based or otherwise, that the dog could reach?' — is not just good medicine. It is an ethical obligation that protects the animal, the owner, and the diagnostic timeline.